Intraocular pressure outcome of patients with fluocinolone acetonide intravitreal implant for noninfectious uveitis

Kathryn Bollinger, James Kim, Careen Y. Lowder, Peter K. Kaiser, Scott D. Smith

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Purpose: To evaluate the intraocular pressure (IOP) outcomes of patients with noninfectious posterior uveitis treated with a fluocinolone acetonide (FA) intravitreal implant over an 8-year period. Design: Retrospective clinical case series. Participants: Forty-seven eyes of 35 patients. Methods: Retrospective review of medical records of all patients receiving FA implants between June 2001 and March 2009 was performed. Data were pooled to record visual acuity (VA) and to characterize the incidence and outcome of glaucoma surgical intervention. Main Outcome Measures: Incidence of glaucoma surgery and IOP before and after glaucoma surgical intervention. Visual acuity before and after FA implant placement. Results: Nineteen of 42 eyes (45%) receiving FA implants over the course of the study period required glaucoma surgical intervention. Success of IOP-lowering surgery was achieved in 94%, 94%, and 92% of eyes at 6, 12, and 24 months postoperatively. No patient lost more than 1 line of VA. There was an average 2-line gain of acuity at 3 years after FA implant placement for those patients who underwent IOP-lowering surgery. Conclusions: Patients receiving FA implants have a significant risk of increased IOP that frequently necessitates glaucoma surgery. Glaucoma surgery, when necessary, offers an effective method to decrease IOP. Financial Disclosure(s): Proprietary or commercial disclosure may be found after the references.

Original languageEnglish (US)
Pages (from-to)1927-1931
Number of pages5
JournalOphthalmology
Volume118
Issue number10
DOIs
StatePublished - Oct 1 2011

Fingerprint

Fluocinolone Acetonide
Uveitis
Intraocular Pressure
Glaucoma
Visual Acuity
Disclosure
Posterior Uveitis
Incidence
Medical Records
Outcome Assessment (Health Care)

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Intraocular pressure outcome of patients with fluocinolone acetonide intravitreal implant for noninfectious uveitis. / Bollinger, Kathryn; Kim, James; Lowder, Careen Y.; Kaiser, Peter K.; Smith, Scott D.

In: Ophthalmology, Vol. 118, No. 10, 01.10.2011, p. 1927-1931.

Research output: Contribution to journalArticle

Bollinger, Kathryn ; Kim, James ; Lowder, Careen Y. ; Kaiser, Peter K. ; Smith, Scott D. / Intraocular pressure outcome of patients with fluocinolone acetonide intravitreal implant for noninfectious uveitis. In: Ophthalmology. 2011 ; Vol. 118, No. 10. pp. 1927-1931.
@article{323a70cb97714be989dc81a101938c5d,
title = "Intraocular pressure outcome of patients with fluocinolone acetonide intravitreal implant for noninfectious uveitis",
abstract = "Purpose: To evaluate the intraocular pressure (IOP) outcomes of patients with noninfectious posterior uveitis treated with a fluocinolone acetonide (FA) intravitreal implant over an 8-year period. Design: Retrospective clinical case series. Participants: Forty-seven eyes of 35 patients. Methods: Retrospective review of medical records of all patients receiving FA implants between June 2001 and March 2009 was performed. Data were pooled to record visual acuity (VA) and to characterize the incidence and outcome of glaucoma surgical intervention. Main Outcome Measures: Incidence of glaucoma surgery and IOP before and after glaucoma surgical intervention. Visual acuity before and after FA implant placement. Results: Nineteen of 42 eyes (45{\%}) receiving FA implants over the course of the study period required glaucoma surgical intervention. Success of IOP-lowering surgery was achieved in 94{\%}, 94{\%}, and 92{\%} of eyes at 6, 12, and 24 months postoperatively. No patient lost more than 1 line of VA. There was an average 2-line gain of acuity at 3 years after FA implant placement for those patients who underwent IOP-lowering surgery. Conclusions: Patients receiving FA implants have a significant risk of increased IOP that frequently necessitates glaucoma surgery. Glaucoma surgery, when necessary, offers an effective method to decrease IOP. Financial Disclosure(s): Proprietary or commercial disclosure may be found after the references.",
author = "Kathryn Bollinger and James Kim and Lowder, {Careen Y.} and Kaiser, {Peter K.} and Smith, {Scott D.}",
year = "2011",
month = "10",
day = "1",
doi = "10.1016/j.ophtha.2011.02.042",
language = "English (US)",
volume = "118",
pages = "1927--1931",
journal = "Ophthalmology",
issn = "0161-6420",
publisher = "Elsevier Inc.",
number = "10",

}

TY - JOUR

T1 - Intraocular pressure outcome of patients with fluocinolone acetonide intravitreal implant for noninfectious uveitis

AU - Bollinger, Kathryn

AU - Kim, James

AU - Lowder, Careen Y.

AU - Kaiser, Peter K.

AU - Smith, Scott D.

PY - 2011/10/1

Y1 - 2011/10/1

N2 - Purpose: To evaluate the intraocular pressure (IOP) outcomes of patients with noninfectious posterior uveitis treated with a fluocinolone acetonide (FA) intravitreal implant over an 8-year period. Design: Retrospective clinical case series. Participants: Forty-seven eyes of 35 patients. Methods: Retrospective review of medical records of all patients receiving FA implants between June 2001 and March 2009 was performed. Data were pooled to record visual acuity (VA) and to characterize the incidence and outcome of glaucoma surgical intervention. Main Outcome Measures: Incidence of glaucoma surgery and IOP before and after glaucoma surgical intervention. Visual acuity before and after FA implant placement. Results: Nineteen of 42 eyes (45%) receiving FA implants over the course of the study period required glaucoma surgical intervention. Success of IOP-lowering surgery was achieved in 94%, 94%, and 92% of eyes at 6, 12, and 24 months postoperatively. No patient lost more than 1 line of VA. There was an average 2-line gain of acuity at 3 years after FA implant placement for those patients who underwent IOP-lowering surgery. Conclusions: Patients receiving FA implants have a significant risk of increased IOP that frequently necessitates glaucoma surgery. Glaucoma surgery, when necessary, offers an effective method to decrease IOP. Financial Disclosure(s): Proprietary or commercial disclosure may be found after the references.

AB - Purpose: To evaluate the intraocular pressure (IOP) outcomes of patients with noninfectious posterior uveitis treated with a fluocinolone acetonide (FA) intravitreal implant over an 8-year period. Design: Retrospective clinical case series. Participants: Forty-seven eyes of 35 patients. Methods: Retrospective review of medical records of all patients receiving FA implants between June 2001 and March 2009 was performed. Data were pooled to record visual acuity (VA) and to characterize the incidence and outcome of glaucoma surgical intervention. Main Outcome Measures: Incidence of glaucoma surgery and IOP before and after glaucoma surgical intervention. Visual acuity before and after FA implant placement. Results: Nineteen of 42 eyes (45%) receiving FA implants over the course of the study period required glaucoma surgical intervention. Success of IOP-lowering surgery was achieved in 94%, 94%, and 92% of eyes at 6, 12, and 24 months postoperatively. No patient lost more than 1 line of VA. There was an average 2-line gain of acuity at 3 years after FA implant placement for those patients who underwent IOP-lowering surgery. Conclusions: Patients receiving FA implants have a significant risk of increased IOP that frequently necessitates glaucoma surgery. Glaucoma surgery, when necessary, offers an effective method to decrease IOP. Financial Disclosure(s): Proprietary or commercial disclosure may be found after the references.

UR - http://www.scopus.com/inward/record.url?scp=80053583998&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053583998&partnerID=8YFLogxK

U2 - 10.1016/j.ophtha.2011.02.042

DO - 10.1016/j.ophtha.2011.02.042

M3 - Article

C2 - 21652079

AN - SCOPUS:80053583998

VL - 118

SP - 1927

EP - 1931

JO - Ophthalmology

JF - Ophthalmology

SN - 0161-6420

IS - 10

ER -